▼ SELL
10b5-1 Plan
$ Value
$100K
Shares
5,000
Price
$20
Filed
Oct 29
Insider
Name
Goeltz II Robert C.
Title
Chief Financial Officer
CIK
0001653881
Roles
Officer
Transaction Details
Transaction Date
2025-10-28
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
92,138
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.
Filing Info
Goeltz II Robert C.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-23 | RCUS | A | $0 |
| 2026-01-23 | RCUS | A | $0 |
| 2025-12-31 | RCUS | ▼ | $153K |
| 2025-12-17 | RCUS | ▼ | $132K |
| 2025-12-16 | RCUS | ▼ | $147K |
| 2025-11-26 | RCUS | ▼ | $125K |
| 2025-10-28 | RCUS | ▼ | $100K |
Other Insiders at RCUS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ROSEN TERRY J
Chief Executive Officer
|
— | — | 2026-01-23 |
|
Jaen Juan C.
President
|
— | — | 2026-01-23 |
|
Goeltz II Robert C.
Chief Financial Officer
|
— | — | 2026-01-23 |
|
Jarrett Jennifer
Chief Operating Officer
|
— | — | 2026-01-23 |
|
Azoy Alexander
Chief Accounting Officer
|
— | — | 2026-01-23 |
|
Tang Carolyn C.
General Counsel
|
— | — | 2026-01-23 |
|
Markus Richard
Chief Medical Officer
|
— | — | 2026-01-23 |